Product Information
BUMETANIDE 0.5 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.1356 per EA under NDC 00832054011. Its NADAC has been published 434 times since Mar 7, 2018.
Strength
.5 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832054011
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209916On Market Since
1/30/2018
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 0.5 MG TABLET has been published 434 times since Mar 7, 2018, and over the history we have for it it has declined 76.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1356 per EA |
|---|---|
| All-time high | $0.6244 (Sep 11, 2019) |
| All-time low | $0.1213 (May 22, 2024) |
| 52-week high | $0.1658 |
| 52-week low | $0.1265 |
| Median price | $0.2305 |
| Average price | $0.2978 |
| Largest weekly change | +29.3% (Jun 19, 2024) |
| Weeks tracked | 434 |
| Tracking since | Mar 7, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the BUMETANIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BUMETANIDE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 0.5 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1356 per EA (NDC 00832054011), effective Jun 24, 2026.
How has the price of BUMETANIDE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 0.5 MG TABLET has declined 76.7%. It has been tracked across 434 weekly CMS publications since Mar 7, 2018.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 0.5 MG TABLET?
Since Mar 7, 2018, the NADAC for BUMETANIDE 0.5 MG TABLET has ranged from a low of $0.1213 (May 22, 2024) to a high of $0.6244 (Sep 11, 2019), with a median of $0.2305 per EA.
Are there cheaper alternatives to BUMETANIDE 0.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BUMETANIDE 0.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures BUMETANIDE 0.5 MG TABLET?
BUMETANIDE 0.5 MG TABLET (NDC 00832054011) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification